← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 9, 2016Last known activity
Oct 24, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 15 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Recent trials (21)
- NCT05726084Lead sponsorPhase 2/Phase 3Oct 24, 2022
- NCT05726084Study directorPhase 2/Phase 3Oct 24, 2022
- NCT05739474Study directorPhase 3Jan 19, 2022
- NCT05739474Lead sponsorPhase 3Jan 19, 2022
- NCT05156723Lead sponsorPhase 1/Phase 2Jul 19, 2021
- NCT05308212Lead sponsorPhase 2/Phase 3Mar 4, 2021
- NCT05470582Lead sponsorPhase 3Feb 16, 2021
- NCT05470582Study directorPhase 3Feb 16, 2021
- NCT05208996CollaboratorPhase 1Jan 22, 2021
- NCT05312294Lead sponsorPhase 3Dec 7, 2020
- NCT05869201Study directorPhase 2/Phase 3Oct 6, 2020
- NCT05869201Lead sponsorPhase 2/Phase 3Oct 6, 2020
- NCT05089123Lead sponsorPhase 3Mar 3, 2020
- NCT05317767Lead sponsorPhase 3Feb 10, 2020
- NCT05457894Lead sponsorPhase 3Jan 23, 2020
Details
- Last known activity
- Oct 24, 2022